Benzinga - Gainers
- Expion360 Inc. (NASDAQ: XPON) shares jumped 175% to $2.70 after the company announced it has been selected as the exclusive supplier of high-energy lithium ion batteries for an overland trailer to be branded and sold by a top U.S. sports utility vehicle manufacturer.
- AMC Entertainment Holdings, Inc. (NYSE: APE) rose 50% to $1.79 after jumping 75% on Thursday. AMC announced it would sell APE units to Antara Capital at an average price of $0.66 per share.
- Immuron Limited (NASDAQ: IMRN) rose 44.2% to $2.4963 after the company received FDA approval for Travelan IND application.
- Core Scientific, Inc. (NASDAQ: CORZ) rose 41.8% to $0.1250 after gaining 73% on Thursday. Core Scientific recently filed for Chapter 11 bankruptcy.
- Concord Medical Services Holdings Limited (NYSE: CCM) gained 24.3% to $1.69.
- iMedia Brands, Inc. (NASDAQ: IMBI) shares rose 23.4% to $0.5797 after the company agreed to sell three buildings for $48 million.
- Edesa Biotech, Inc. (NASDAQ: EDSA) gained 22.4% to $2.29.
- Blue Apron Holdings, Inc. (NYSE: APRN) rose 20.3% to $1.1489 after gaining over 11% on Thursday.
- DBV Technologies S.A. (NASDAQ: DBVT) shares rose 20% to $1.41 after the company announced the FDA has lifted the partial clinical hold on its VITESSE Phase 3 Pivotal Trial.
- TuSimple Holdings Inc. (NASDAQ: TSP) jumped 18.6% to $1.4950.
- Omeros Corporation (NASDAQ: OMER) shares gained 16.9% to $2.98. Omeros, last month, posted a narrower-than-expected quarterly loss.
- Exela Technologies, Inc. (NASDAQ: XELA) surged 12% to $0.0955.
- Viveve Medical, Inc. (NASDAQ: VIVE) gained 12% to $0.4025.
- Airspan Networks Holdings Inc. (NYSE: MIMO) jumped 11.2% to $1.14.
- Hallador Energy Company (NASDAQ: HNRG) shares gained 10.9% to $10.86.
- Nine Energy Service, Inc. (NYSE: NINE) jumped 9.8% to $13.22.
- Versus Systems Inc. (NASDAQ: VS) rose 9.8% to $0.5160 after gaining 9% on Thursday. Versus recently announced pricing of a $2.1 million public offering.
- Vigil Neuroscience, Inc. (NASDAQ: VIGL) gained 9.7% to $11.11.
- BiomX Inc. (NYSE: PHGE) jumped 9.7% to $0.21.
- CPI Card Group Inc. (NASDAQ: PMTS) rose 9.1% to $35.00.
- ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) gained 8% to $5.17. ORIC Pharmaceuticals recently announced it entered into a clinical development collaboration for a potential Phase 2 study of ORIC-533 in multiple myeloma with Pfizer (NYSE:PFE) and agreed to sell about 5.38 million of its common shares at a price of $4.65 per share to Pfizer for proceeds of approximately $25 million.
- Applied Molecular Transport Inc. (NASDAQ: AMTI) shares dipped 55.7% to $0.4560 after the company announced top-line Phase 2 results from the LOMBARD monotherapy trial, in which the company saw similar clinical remission rates in patients receiving AMT-101 compared to the placebo at week 12.
- MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares dipped 48% to $1.85. MingZhu Logistics recently announced a $34 million transportation agreement with Xinjiang Tianfu Yitong Supply Chain Management.
- E-Home Household Service Holdings Limited (NASDAQ: EJH) shares fell 48% to $0.69 after jumping 92% on Thursday. E-Home Household Services recently entered into definitive equity transfer agreement for acquisition of 20% equity interests in Zhongrun Pharmaceutical.
- NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) dropped 39.6% to $0.7791.
- Dragonfly Energy Holdings Corp. (NASDAQ: DFLI) fell 25.8% to $11.03. Dragonfly Energy recently secured a patent from the United States Patent and Trademark Office (USPTO).
- Miromatrix Medical Inc. (NASDAQ: MIRO) dropped 25% to $2.1001. The FDA recently announced a clinical hold on the company's IND application for miroliverELAP.
- Renren Inc. (NYSE: RENN) fell 23% to $1.40. Renren recently announced special cash distribution of $31.5585 per ADS.
- Kalera Public Limited Company (NASDAQ: KAL) fell 17.5% to $7.91. On December 22, 2022, Kalera shareholders approved a 1-for-100 reverse stock split.
- Bakkt Holdings, Inc. (NYSE: BKKT) fell 16.4% to $1.2699.
- Kalera Public Limited Company (NYSE: KAL) dropped 16.3% to $8.04
- Remark Holdings, Inc. (NASDAQ: MARK) fell 15.6% to $1.0207.
- Cabaletta Bio, Inc. (NASDAQ: CABA) dropped 15.5% to $7.86. Cabaletta Bio recently announced a $35 million offering,
- Mission Produce Inc (NASDAQ: AVO) fell 15.1% to $12.40 after the company reported weaker-than-expected results for its fourth quarter on Thursday.
- Gaucho Group Holdings, Inc. (NASDAQ: VINO) dipped 15% to $1.02.
- Dada Nexus Limited (NASDAQ: DADA) fell 14% to $6.54.
- Ever-Glory International Group, Inc. (NASDAQ: EVK) dropped 14.2% to $0.3432. Ever-Glory announced voluntary delisting from the Nasdaq Global Market.
- Connexa Sports Technologies Inc. (NASDAQ: CNXA) fell 11% to $0.2225 after jumping 24% on Thursday.
- TAL Education Group (NYSE: TAL) dropped 10.8% to $8.99.
- AMC Entertainment Holdings, Inc. (NYSE: AMC) fell 10.8% to $4.3797. AMC Entertainment Holdings announced an equity capital raise and a debt for equity exchange.
- Atai Life Sciences N.V. (NASDAQ: ATAI) dropped 10% to $2.7208. The company reported results from the Kures Therapeutics Phase 1 trial of KUR-10.
- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) declined 9.4% to $17.39. B of A Securities maintained Rocket Pharmaceuticals with a Buy and lowered the price target from $38 to $35.
- Acasti Pharma Inc. (NASDAQ: ACST) shares fell 8.8% to $0.5017. Acasti Pharma recently said preliminary topline results met all primary outcome measures in single dose pharmacokinetic study for GTX-101.
- Li Auto Inc. (NASDAQ: LI) fell 8.1% to $18.77.
- Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) dropped 8.1% to $12.38. Intercept resubmitted New Drug Application to the FDA For obeticholic acid in patients with liver fibrosis due to NASH.
- Berkeley Lights, Inc. (NASDAQ: BLI) fell 5.7% to $2.81. Berkeley Lights agreed to acquire IsoPlexis in an all-stock transaction valued at $57.8 million.
- Limoneira Co (NASDAQ: LMNR) fell 4.1% to $12.79. Limoneira posted a wider-than-expected loss for its fourth quarter, while sales topped estimates.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.